tolaini test

Salary:

£60000 - £61000 per annum

Options Biotechnology, Permanent, Statistics, France, Not Applicable
Location:

Paris, France

Description

An exciting opportunity has arisen for a Senior Statistician be responsible for statistical aspects of clinical and preclinical research projects with exposure to a range of therapeutic areas.

Reference:

37101

Salary:

£60000 - £61000 per annum

Options Biotechnology, Permanent, Clinical Trial Assistant (CTA), United Kingdom, Not Applicable
Location:

London, England

Description

A world leading pharmaceutical company is in search of a talented Clinical Trial Specialist to perform essential responsibilities for successful trial.

Reference:

37100

Salary:

£50000 - £51000 per annum

Options Biotechnology, Permanent, Consultant / Specialist, United Kingdom, Not Applicable
Location:

London, England

Description

Proclinical is currently recruiting a Senior Regulatory Specialist in London, this is also a remote opportunity.

Reference:

37099

Salary:

£70000 - £71000 per annum

Options Biotechnology, Permanent, Medical Advisor, United Kingdom, Not Applicable
Location:

London, England

Description

Proclinical have partnered with a large pharmaceutical company in search for a dynamic Medical Doctor within their UK and Ireland regions.

Reference:

37098

Salary:

£45000 - £46000 per annum

Options Biotechnology, Permanent, Laboratory Technician, Switzerland, Not Applicable
Location:

Basel, Switzerland

Description

A new and exciting role has arisen for a Computational Scientist in Switzerland.

Reference:

37087

Salary:

Highly Competitive

Options Biotechnology, Permanent, Analytical Chemistry, Switzerland, Not Applicable
Location:

Nyon, Switzerland

Description

We are in search for a Senior CMC Analytical Lifecycle Manager to supply Analytical strategic and scientific expertise to CMC Development Teams in support of submissions to Regulatory authorities.

Reference:

37081

Salary:

Highly Competitive

Options Biotechnology, Permanent, CMC, Switzerland, Not Applicable
Location:

Nyon, Switzerland

Description

A fantastic vacancy has become available for a Director CMC Lead in France.

Reference:

35343

Salary:

Highly Competitive

Options Other, Permanent, Medical Writing, Netherlands, Not Applicable
Location:

Amsterdam, Netherlands

Description

Proclinical has partnered with a Medical Communications company in London and Amsterdam

Reference:

34844

Salary:

Highly Competitive Salary

Options All, Pharmaceuticals, Permanent, Publishing & Submissions, RA Intelligence, United States, Not Applicable
Location:

Sacramento, USA

Description

Proclinical is currently recruiting for a Regulatory Coordinator with a pharmaceutical company located in Sacramento, CA.

Reference:

RA.BC.37090

German life science market

5 reasons why the German life science market keeps on growing

Renowned for its leading scientists, innovative start-ups and first-class hospitals, it’s no surprise Germany is the largest market for healthcare and life science products in Europe. World-class manufacturers and providers drive a life science industry that delivers a wide range of pharmaceuticals, medical technology, biotechnology and medical devices to patients all over the globe.Here we look at some of the many reasons Germany is such an attractive market for life science companies:1. A robust economyGermany has the largest economy in Europe and is the fourth largest national economy by GDP in the world after the US, China and Japan. Known as an economic powerhouse, the country has a strong focus on exports making it a truly competitive global player. In 2020, Germany shipped an impressive US$1.38 trillion worth of goods across the world, with pharmaceuticals, the fastest-growing category for exports, accounting for 7.1% of that, and optical, technical, medical apparatus accounting for 5.4%.Ground-breaking scientific research coupled with a highly-skilled workforce has created a limitless environment for innovation, and as a result, over one thousand medical technology patents granted in 2020. With health expenditure in Germany over €390 billion (€4,712 per citizen), new ways to improve health easily find a market.Many of these exciting and advanced new concepts are generated by what is known as the “Mittelstand” – small and medium-sized enterprises which are key component of Germany’s robust economy.2. Strong InfrastructureLocated at the heart of the intersection of Central and Western Europe, Germany provides easy access to a number of global cities including London, Amsterdam and Paris. Germany offers well-developed infrastructure and sophisticated logistics services, making it straightforward for life science companies to distribute products across the world.Internationally recognised for its leading facilities, Germany is home to several important facilities including: The Fraunhofer Institute, including the Department of Biomedical Technology, the Helmholtz Association of German Research Centres, the Robert-Koch Institute, the Paul-Ehrlich Institute and the Leibniz Association. It’s strong research infrastructure provides a solid basis for the development of treatments and medical technology.3. Leaders in innovation Forward-thinking and dynamic, Germany is at the cutting edge of medical advancements. Backed by billions of euros in annual federal funds and well-equipped with the latest in technology, Germany is the ideal spot for R&D efforts. With its high commitment to driving new solutions, it’s unsurprising Germany is Europe's leading patent applicant, which frequently leads to commercialisation of pioneering technology. In 2020, the annual Bloomberg Innovation Index named Germany as the most technologically advanced nation, followed by South Korea and Singapore. Germany scored three top-five rankings – in value-added manufacturing, high-tech density, and patent activity – making it a clear winner.4. World-class manufacturing capabilitiesGermany has a longstanding history in manufacturing excellence. From some of the world's most well-known automotive brands to progressive medical instruments, it is one of the most competitive markets for manufacturing in world.Germany is the European Union’s leading pharma manufacturing location and is the third largest producer of medical technology worldwide. It’s efficient processes, advanced facilities and pioneering technology make it a great location for life science companies to produce their medical solutions.5. Access to talentDriven by an outstanding education system and top academic and research institutes, Germany has access to wide pool of talent. According to the Times Higher Education World University Rankings 2021, 48 universities in Germany are counted among the very best in the world. A remarkable, 81% of the German population have been trained to university entrance level or equivalent.Germany’s opportunities for innovation and high-quality living standards make it an attractive location for life science professionals to relocate to. With straightforward entry requirements, Germany appeals to life science experts from across the world.Interested in finding out more about how we can help you achieve growth in Germany? Contact our Frankfurt team to learn more.

Read full article
Acacium Group acquires life sciences consulting company

Acacium Group acquires life sciences consulting company

Proclinical, part of Acacium Group, is pleased to announce that Acacium Group has completed the acquisition of US-based life sciences and regulatory affairs consulting company Dunn Regulatory Associates.The acquisition strengthens Acacium Group’s international life sciences division whilst enabling Dunn Regulatory Associates to benefit from the group’s global resources. This partnership will benefit both sides immensely, increasing resource capability and providing a wider service offering, which will further develop our client relationships. Paul Strouts, Life Sciences CEO, says, “We were very impressed by Dunn Regulatory Associates’ business and their shared values of improving lives by supporting innovative businesses in the global life sciences sector. We are delighted to welcome them to Acacium Group, where they perfectly complement the existing range of services provided by Proclinical. Together our access to brilliant talent in the life science sector and combined focus on people first will underpin everything we do, whether deploying workforce or delivering services for clients.” For more information, contact mediaenquiries@acaciumgroup.com.

Read full article

Global expansion guidebook

Read full article

Guidebook: How to stand out at your interview

Read full article

Guidebook: creating a successful CV

Read full article

Cell-gene therapy CDMO, aseptic team build-out

Cell-gene therapy CDMO, aseptic team build-out Case study The overview Our partner, a leader in cell-gene therapy, engaged us to build out their aseptic team, taking over from a third-party vendor. The challengeWe were approached as a partner of choice to support an aseptic manufacturing build out in Philadelphia. We were requested to submit a proposal, alongside multiple agencies, for expanding their aseptic disinfecting team as the current third-party vendor wasn’t meeting regulation expectations. As the company was rapidly growing, they needed to have a team of contractors that they could rely on. The proposal was comprised of a detailed breakdown of how we would support and complete the project, including timelines, compliance, pricing and dedicated resources. Our team won the project exclusively, which was to be completed whilst we also continued to recruit across other divisions for the same partner. The main challenge was the tight timeframes – the company required 30 hires in 8 weeks, ready for a full takeover from the third-party vendor. The roles required contractors to work the night shift, so a further challenge was to find suitable candidates with the correct aseptic experience willing to work those hours. The solutionThis was a unique project so we had to create a new pool of suitable candidates. We utilised our existing network for referrals, which proved highly successful, and market mapped using recruiting tools such as CareerBuilder, Monster, and LinkedIn Recruiter. We were able to follow our proposal plan carefully and accurately, scheduling interviews every week for 3 months to ensure rapid delivery against the tight timelines. We worked closely with the TA team, keeping communication open and informative, to allow a truly collaborative approach to the project. The project ran successfully and the 30 hires were completed by the agreed deadline. Our team handled the onboarding procedures, working with HR to ensure a smooth process, including background checks, drug screens, and referencing. The third-party vendor was phased out, and the team is now staffed by our contractors. The outcome We successfully delivered on the project whilst also completing delivery for assignments within Manufacturing, Lab Testing and R&D 30 contractors on site for the aseptic project, and a further 30 on site in different teams We continue to support our partner across various functions and a dedicated account manager frequently spends time on site to continue to support the day-to-day matters of the contractors, building and maintaining a long-lasting relationship  

Read full article

Cell-gene therapy company, new facility development

Cell-gene therapy company, new facility development Case study The overview A leader in cell-gene therapy partnered with us to build their scientific teams ready for the launch of a brand-new manufacturing facility. The challengeThey needed to build strong teams in order to make sure the new facility would be up and running in the given timelines. The fact that it was an aseptic facility meant that the candidate pool was restricted to those with this specific background. They had their own recruitment team on site, but were unable to engage the right networks, and could not thoroughly communicate to the market exactly what the company was trying to achieve. Therefore, they approached our team in need of specialised scientific recruiters. Our challenge was to find candidates with an aseptic background, whilst educating them about this new facility and the company’s future plans. The solutionWe conducted extensive market mapping of subject matter experts, utilising our unparalleled knowledge of the market and region, and mobilised local language speakers. This ensured that candidates were spoken to in their own language and created a smoother experience for both candidate and our partner. Our scientific consultants had an existing strong network with aseptic environment experience and were able to tap into this to provide immediate shortlists for our partner. We worked with their in-house team to provide a permanent and contract solution that complemented different candidate’s skillsets and allowed a myriad of people to contribute to the facility. We offered our expert advice on which candidates would be needed on a contract basis and which would be better taken on permanently, with the best interests of the development of the site at heart. We communicated frequently with our partner via conference calls to establish a strong relationship and ensure consistent feedback. The outcome We successfully completed the project within the agreed deadlines 3 senior hires were made with our help - 2 QC managers and a senior scientist We continue to work with the company on scientific roles  

Read full article

Scandinavian CRO, expansion into Western Europe

Scandinavian CRO, expansion into Western Europe Case study The overview A Scandinavian based CRO, partnered with us exclusively to assist with their expansion into Western Europe, beginning with a senior CRA position in Germany. The challengeOur partner had a strong brand reputation in Scandinavia, but in Central and Western Europe the brand was largely unknown. They wanted to open offices in Munich initially, and needed assistance understanding the local culture and identifying candidates who would be able adapt to the specific mindset of the company. We needed to educate potential candidates on our partner, their values, and their reputation. This was a challenging role to fill as it was a niche area to source in, with a narrow and specific pool from which to highlight and engage suitable candidates. Our partner perceived themselves as being entrepreneurial in nature, with a ‘sleeves rolled up’ mentality, and wanted people with a similar work ethic. The solutionThe organisation partnered with us exclusively, which afforded us the opportunity to communicate a consistent message to the professional community. We worked with the business development director to educate the line manager on recruitment best practice which helped to align the interview process internally. This created an education piece around unique challenges in each location and managed expectations accordingly. We conducted market mapping across the DACH region, utilising headhunting tools such as LinkedIn Recruiter and Xing, and engaged with our legacy candidates. We utilised our multilingual capabilities by mobilising our team of regional clinical operations experts to connect with local networks, ensuring that candidates were spoken to in their own language. This created a smoother experience for both candidate and our partner. We submitted 3 candidates to our partner, 2 of which were interviewed. The outcome Through collaboration with us, the successful hire was made through a recommendation from within our network We educated the market on our partner and their plans moving forward, building a talent pool of exceptional individuals for our partner’s future needs Based on the success of the initial hire, our team was asked to continue supporting the expansion with a further 5 hires in Munich, and placements in the UK, Czech Republic, and Benelux  

Read full article

US biopharma, expansion into Europe

US biopharma, expansion into Europe Case study The overview A US based rare disease biopharmaceutical company, partnered with us to build out their regional key account managers team in the DACH region for an upcoming European wide product launch. The challengeWe were retained on an exclusive basis to support the preparations for an expected product launch the following year. We were initially engaged to search for a commercial lead, which we did successfully, and were then tasked with recruiting multiple regional key account managers across the DACH region, who would support market penetration in 2018. The key challenge was sourcing local talent with the appropriate skillsets in the niche area of rare disease. The solutionWe conducted extensive market mapping of subject matter experts, utilising our unparalleled knowledge of the market and region, and mobilised local language speakers. This ensured that candidates were spoken to in their own language and created a smoother experience for both candidate and our partner. A shortlist of 27 candidates was presented, 15 of which had initial telephone conversations. In partnership with the company, we ran two assessment centres in Munich where a total of 9 candidates were interviewed. These were well received by the candidates, and our partner was impressed by the smooth running of the process. The outcome We successfully worked to the agreed deadline of 8 weeks to help our partner hire 5 regional key account managers for the DACH territory We continue to support the company across multiple divisions  

Read full article

Global pharma, growth of regulatory affairs division

Global pharma, growth of regulatory affairs division Case study The overview A global pharmaceutical organisation partnered with us to source a niche hire within their emerging markets regulatory affairs team. The challengeOur partner was looking for a regulatory affairs liaison to focus on the Chinese and Japanese markets. This is an extremely niche area within regulatory affairs and therefore a challenging role to fill. The talent pool was very limited within a tough location, and internal searches had not yielded any success so far. They had explored the option of having local workers based remotely, but this had not proved successful. The solutionWe advised that to fill this role, a contract solution would be the best option, rather than the contingent option previously considered by our partner. We suggested that 2 part-time consultants could share the role, therefore completing the five-day quota but with a 2-day and 3-day workers. From our existing network, well-referenced consultants who had been part of our contractor base for 10 years were shortlisted. We advised our partner on rates and pay structures, as this wasn’t a solution they had used before, and were able to educate them on the current market, which dictated that a more flexible workforce was required. We provided a shortlist of 8 candidates, with full-time and part-time options, including a variety of rates and levels of expertise. The outcome Our partner opted for the part-time solution, and 2 candidates were successfully hired The project was delivered within the agreed timelines and budget Following this success, they have now partnered with us across their medical affairs, clinical, and pharmacovigilance divisions The relationship has been consolidated further with them choosing us to be their sole supplier for UK and APAC regulatory affairs  

Read full article
close